Skip to main content

Advertisement

Open Peer Review Reports for: Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
22 Nov 2017 Submitted Original manuscript
4 Dec 2017 Author responded Author comments - Philippe ROCHIGNEUX
Resubmission - Version 2
4 Dec 2017 Submitted Manuscript version 2
8 Jun 2018 Reviewed Reviewer Report - Ulka Vaishampayan
21 Jun 2018 Reviewed Reviewer Report - Cristina Rodriguez-Antona
26 Jun 2018 Reviewed Reviewer Report - Andrew S Protheroe
24 Oct 2018 Author responded Author comments - Philippe ROCHIGNEUX
Resubmission - Version 3
24 Oct 2018 Submitted Manuscript version 3
25 Oct 2018 Reviewed Reviewer Report - Cristina Rodriguez-Antona
25 Oct 2018 Reviewed Reviewer Report - Ulka Vaishampayan
2 Nov 2018 Reviewed Reviewer Report - Andrew S Protheroe
4 Nov 2018 Author responded Author comments - Philippe ROCHIGNEUX
Resubmission - Version 4
4 Nov 2018 Submitted Manuscript version 4
Publishing
6 Nov 2018 Editorially accepted
22 Nov 2018 Article published 10.1186/s12885-018-5049-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement